Alliance Biochem Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.12 M
- Company Age 17 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 1.20 M
- Revenue Growth -12.26%
- Profit Growth -44.88%
- Ebitda -1.74%
- Net Worth 3.48%
- Total Assets 8.62%
About Alliance Biochem
Alliance Biochem Private Limited (ABPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 August 2007 and has a history of 17 years and five months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Corporate was formerly known as Shyam Medicines Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.12 M.
The company currently has active open charges totaling ₹1.20 M.
Shalini Srivastava and Vijay Srivastava serve as directors at the Company.
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U21023UP2007PTC033789
- Company No.
033789
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2007
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Alliance Biochem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shalini Srivastava  | Director | 20-Jan-2009 | Current |
| Vijay Srivastava | Director | 20-Jan-2009 | Current |
Financial Performance of Alliance Biochem.
Alliance Biochem Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 12.26% decrease. The company also saw a substantial fall in profitability, with a 44.88% decrease in profit. The company's net worth moved up by a moderate rise of 3.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alliance Biochem?
In 2018, Alliance Biochem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.20 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 May 2019 | Others | ₹1.20 M | Open |
How Many Employees Work at Alliance Biochem?
Unlock and access historical data on people associated with Alliance Biochem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alliance Biochem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alliance Biochem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
